{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:00:42Z","timestamp":1790992842965,"version":"4.1.0"},"reference-count":80,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2020,6,9]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Mood disorders include Major Depressive Disorder (MDD), Bipolar Disorder (BD) and\nvariations of both. Mood disorders has a public health significance with high comorbidity, suicidal\nmortality and economic burden on the health system. Research related to mood disorders has\nevolved over the years to relate it with systemic conditions. The Renin Angiotensin System (RAS)\nhas been noticed to play major physiological roles beyond renal and cardiovascular systems. Recent\nstudies have linked RAS not only with neuro-immunological processes, but also with psychiatric\nconditions like mood and anxiety disorders. In this comprehensive review, we integrated basic and\nclinical studies showing the associations between RAS and mood disorders. Animal studies on\nmood disorders models - either depression or mania - were focused on the reversal of behavioral\nand\/or cognitive symptoms through the inhibition of RAS components like the Angiotensin-\nConverting Enzyme (ACE), Angiotensin II Type 1 receptor (AT1) or Mas receptors. ACE\npolymorphisms, namely insertion-deletion (I\/D), were linked to mood disorders and suicidal\nbehavior. Hypertension was associated with neurocognitive deficits in mood disorders, which\nreversed with RAS inhibition. Low levels of RAS components (renin activity or aldosterone) and\nmood symptoms improvement with ACE inhibitors or AT1 blockers were also observed in mood\ndisorders. Overall, this review reiterates the strong and under-researched connection between RAS\nand mood disorders.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866527666191223144000","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T12:44:13Z","timestamp":1577105053000},"page":"449-455","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Exploring the Evidence Implicating the Renin-Angiotensin System (RAS) in the Physiopathology of Mood Disorders"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-3025","authenticated-orcid":true,"given":"Satyajit","family":"Mohite","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center, Houston, TX 77054, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-6822","authenticated-orcid":true,"given":"Marsal","family":"Sanches","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center, Houston, TX 77054, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9621-5422","authenticated-orcid":true,"given":"Antonio L.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center, Houston, TX 77054, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596[","author":"Association A.P.","year":"2013","unstructured":"Association A.P.;  Diagnostic and statistical manual of mental disorders (DSM-5) 2013","journal-title":"Diagnostic and statistical manual of mental disorders (DSM-5)"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/mp.2010.101","volume":"16","author":"Alonso J.","year":"2011","unstructured":"Alonso J.; Petukhova M.; Vilagut G.; Chatterji S.; Heeringa S.; \u00dcst\u00fcn T.B.; Alhamzawi A.O.; Viana M.C.; Angermeyer M.; Bromet E.; Bruffaerts R.; de Girolamo G.; Florescu S.; Gureje O.; Haro J.M.; Hinkov H.; Hu C.Y.; Karam E.G.; Kovess V.; Levinson D.; Medina-Mora M.E.; Nakamura Y.; Ormel J.; Posada-Villa J.; Sagar R.; Scott K.M.; Tsang A.; Williams D.R.; Kessler R.C.; Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Mol Psychiatry 2011,16(12),1234-1246","journal-title":"Mol Psychiatry"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/acps.12003","volume":"127","author":"Grande I.","year":"2013","unstructured":"Grande I.; Goikolea J.M.; de Dios C.; Gonz\u00e1lez-Pinto A.; Montes J.M.; Saiz-Ruiz J.; Prieto E.; Vieta E.; Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data). Acta Psychiatr Scand 2013,127(5),403-411","journal-title":"Acta Psychiatr Scand"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1399-5618.2007.00327.x","volume":"9","author":"Martinez-Aran A.","year":"2007","unstructured":"Martinez-Aran A.; Vieta E.; Torrent C.; Sanchez-Moreno J.; Goikolea J.M.; Salamero M.; Malhi G.S.; Gonzalez-Pinto A.; Daban C.; Alvarez-Grandi S.; Fountoulakis K.; Kaprinis G.; Tabares-Seisdedos R.; Ayuso-Mateos J.L.; Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007,9(1-2),103-113","journal-title":"Bipolar Disord"},{"key":"ref=5","unstructured":"Depression and Other Common\n\tMental Disorders: Global Health Estimates. 2017, pp. 1-24. World Health Organization"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"Merikangas K.R.","year":"2011","unstructured":"Merikangas K.R.; Jin R.; He J-P.; Kessler R.C.; Lee S.; Sampson N.A.; Viana M.C.; Andrade L.H.; Hu C.; Karam E.G.; Ladea M.; Medina-Mora M.E.; Ono Y.; Posada-Villa J.; Sagar R.; Wells J.E.; Zarkov Z.; Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011,68(3),241-251","journal-title":"Arch Gen Psychiatry"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"Vos T.","year":"2016","unstructured":"Vos T.; Allen C.; Arora M.; Barber R.M.; Bhutta Z.A.; Brown A.; Carter A.; Casey D.C.; Charlson F.J.; Chen A.Z.; Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016,388(10053),1545-1602","journal-title":"Lancet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"d5422","DOI":"10.1136\/bmj.d5422","volume":"343","author":"Hoang U.","year":"2011","unstructured":"Hoang U.; Stewart R.; Goldacre M.J.; Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006. BMJ 2011,343,d5422","journal-title":"BMJ"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-5618.2009.00786.x","volume":"12","author":"Novick D.M.","year":"2010","unstructured":"Novick D.M.; Swartz H.A.; Frank E.; Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord 2010,12(1),1-9","journal-title":"Bipolar Disord"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/bmj.330.7488.373","volume":"330","author":"Cipriani A.","year":"2005","unstructured":"Cipriani A.; Barbui C.; Geddes J.R.; Suicide, depression, and antidepressants. BMJ 2005,330,373","journal-title":"BMJ"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.4088\/JCP.v66n0604","volume":"66","author":"Hawton K.","year":"2005","unstructured":"Hawton K.; Sutton L.; Haw C.; Sinclair J.; Harriss L.; Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors. J Clin Psychiatry 2005,66(6),693-704","journal-title":"J Clin Psychiatry"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jad.2013.01.004","volume":"147","author":"Hawton K.","year":"2013","unstructured":"Hawton K.; Casa\u00f1as I Comabella C.; Haw C.; Saunders K.; Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord 2013,147(1-3),17-28","journal-title":"J Affect Disord"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2165\/00023210-200317070-00003","volume":"17","author":"Tondo L.","year":"2003","unstructured":"Tondo L.; Isacsson G.; Baldessarini R.; Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs 2003,17(7),491-511","journal-title":"CNS Drugs"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1440-1819.2007.01604.x","volume":"61","author":"Kato T.","year":"2007","unstructured":"Kato T.; Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 2007,61(1),3-19","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/sj.ejhg.5201549","volume":"14","author":"Craddock N.","year":"2006","unstructured":"Craddock N.; Forty L.; Genetics of affective (mood) disorders. Eur J Hum Genet 2006,14(6),660-668","journal-title":"Eur J Hum Genet"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cpr.2005.06.006","volume":"25","author":"Alloy L.B.","year":"2005","unstructured":"Alloy L.B.; Abramson L.Y.; Urosevic S.; Walshaw P.D.; Nusslock R.; Neeren A.M.; The psychosocial context of bipolar disorder: environmental, cognitive, and developmental risk factors. Clin Psychol Rev 2005,25(8),1043-1075","journal-title":"Clin Psychol Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1943-278X.1995.tb00490.x","volume":"25","author":"Brent D.A.","year":"1995","unstructured":"Brent D.A.; Risk factors for adolescent suicide and suicidal behavior: mental and substance abuse disorders, family environmental factors, and life stress. Suicide Life Threat Behav 1995,25(Suppl.),52-63","journal-title":"Suicide Life Threat Behav"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sj.mp.4001585","volume":"10","author":"Strakowski S.M.","year":"2005","unstructured":"Strakowski S.M.; Delbello M.P.; Adler C.M.; The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry 2005,10(1),105-116","journal-title":"Mol Psychiatry"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1001\/archpsyc.60.12.1201","volume":"60","author":"Blumberg H.P.","year":"2003","unstructured":"Blumberg H.P.; Kaufman J.; Martin A.; Whiteman R.; Zhang J.H.; Gore J.C.; Charney D.S.; Krystal J.H.; Peterson B.S.; Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch Gen Psychiatry 2003,60(12),1201-1208","journal-title":"Arch Gen Psychiatry"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.1","volume":"5","author":"Ding Y.","year":"2015","unstructured":"Ding Y.; Lawrence N.; Oli\u00e9 E.; Cyprien F.; le Bars E.; Bonaf\u00e9 A.; Phillips M.L.; Courtet P.; Jollant F.; Prefrontal cortex markers of suicidal vulnerability in mood disorders: a model-based structural neuroimaging study with a translational perspective. Transl Psychiatry 2015,5(2)","journal-title":"Transl Psychiatry"},{"key":"ref=21","doi-asserted-by":"publisher","author":"Price J.L.","unstructured":"Price J.L.; Drevets W.C.;","DOI":"10.1016\/j.tics.2011.12.011"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","volume":"53","author":"Rosenblat J.D.","year":"2014","unstructured":"Rosenblat J.D.; Cha D.S.; Mansur R.B.; McIntyre R.S.; Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 2014,53,23-34","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.lpm.2010.09.019","volume":"40","author":"Baubet T.","year":"2011","unstructured":"Baubet T.; Ranque B.; Ta\u00efeb O.; B\u00e9rezn\u00e9 A.; Bricou O.; Mehallel S.; Moroni C.; Belin C.; Pagnoux C.; Moro M-R.; Guillevin L.; Mouthon L.; Mood and anxiety disorders in systemic sclerosis patients. Presse Med 2011,40(2),e111-e119","journal-title":"Presse Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/mp.2009.112","volume":"15","author":"Kapczinski F.","year":"2010","unstructured":"Kapczinski F.; Dal-Pizzol F.; Teixeira A.L.; Magalhaes P.V.; Kauer-Sant\u2019Anna M.; Klamt F.; Pasquali M.A.; Quevedo J.; Gama C.S.; Post R.; A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry 2010,15(8),784-786","journal-title":"Mol Psychiatry"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.pbb.2008.04.003","volume":"90","author":"Micale V.","year":"2008","unstructured":"Micale V.; Tamburella A.; Leggio G.M.; Mazzola C.; Li Volsi V.; Drago F.; Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions. Pharmacol Biochem Behav 2008,90(3),463-469","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2174\/0929867325666180226102358","volume":"25","author":"Rocha N.P.","year":"2018","unstructured":"Rocha N.P.; Simoes E Silva A.C.; Prestes T.R.R.; Feracin V.; Machado C.A.; Ferreira R.N.; Teixeira A.L.; de Miranda A.S.; RAS in the central nervous system: Potential role in neuropsychiatric disorders. Curr Med Chem 2018,25(28),3333-3352","journal-title":"Curr Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2010.10.001","volume":"36","author":"Saavedra J.M.","year":"2011","unstructured":"Saavedra J.M.; S\u00e1nchez-Lemus E.; Benicky J.; Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology 2011,36(1),1-18","journal-title":"Psychoneuroendocrinology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.schres.2018.06.023","volume":"202","author":"Mohite S.","year":"2018","unstructured":"Mohite S.; de Campos-Carli S.M.; Rocha N.P.; Sharma S.; Miranda A.S.; Barbosa I.G.; Salgado J.V.; Simoes-E-Silva A.C.; Teixeira A.L.; Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia. Schizophr Res 2018,202,50-54","journal-title":"Schizophr Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.pnpbp.2007.04.002","volume":"31","author":"Saab Y.B.","year":"2007","unstructured":"Saab Y.B.; Gard P.R.; Yeoman M.S.; Mfarrej B.; El-Moalem H.; Ingram M.J.; Renin-angiotensin-system gene polymorphisms and depression. Prog Neuropsychopharmacol Biol Psychiatry 2007,31(5),1113-1118","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00702-006-0483-9","volume":"113","author":"Hishimoto A.","year":"2006","unstructured":"Hishimoto A.; Shirakawa O.; Nishiguchi N.; Hashimoto T.; Yanagi M.; Nushida H.; Ueno Y.; Maeda K.; Association between a functional polymorphism in the renin-angiotensin system and completed suicide. J Neural Transm (Vienna) 2006,113(12),1915-1920","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4088\/JCP.11m07316","volume":"73","author":"Khoury N.M.","year":"2012","unstructured":"Khoury N.M.; Marvar P.J.; Gillespie C.F.; Wingo A.; Schwartz A.; Bradley B.; Kramer M.; Ressler K.J.; The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J Clin Psychiatry 2012,73(6),849-855","journal-title":"J Clin Psychiatry"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1515\/JBCPP.2003.14.4.323","volume":"14","author":"Braszko J.J.","year":"2003","unstructured":"Braszko J.J.; Karwowska-Polecka W.; Halicka D.; Gard P.R.; Captopril and enalapril improve cognition and depressed mood in hypertensive patients. J Basic Clin Physiol Pharmacol 2003,14(4),323-343","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/0006-3223(86)90334-3","volume":"21","author":"Deicken R.F.","year":"1986","unstructured":"Deicken R.F.; Captopril treatment of depression. Biol Psychiatry 1986,21(14),1425-1428","journal-title":"Biol Psychiatry"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0006-3223(88)90010-8","volume":"23","author":"Germain L.","year":"1988","unstructured":"Germain L.; Chouinard G.; Treatment of recurrent unipolar major depression with captopril. Biol Psychiatry 1988,23(6),637-641","journal-title":"Biol Psychiatry"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10571-011-9656-7","volume":"31","author":"Nasr S.J.","year":"2011","unstructured":"Nasr S.J.; Crayton J.W.; Agarwal B.; Wendt B.; Kora R.; Lower frequency of antidepressant use in patients on renin-angiotensin-aldosterone system modifying medications. Cell Mol Neurobiol 2011,31(4),615-618","journal-title":"Cell Mol Neurobiol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1176\/ajp.141.1.110","volume":"141","author":"Zubenko G.S.","year":"1984","unstructured":"Zubenko G.S.; Nixon R.A.; Mood-elevating effect of captopril in depressed patients. Am J Psychiatry 1984,141(1),110-111","journal-title":"Am J Psychiatry"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1017\/S0033291700044068","volume":"10","author":"Arregui A.","year":"1980","unstructured":"Arregui A.; Mackay A.V.; Spokes E.G.; Iversen L.L.; Reduced activity of angiotensin-converting enzyme in basal ganglia in early onset schizophrenia. Psychol Med 1980,10(2),307-313","journal-title":"Psychol Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-61779-458-2_7","author":"Overstreet D.H.","year":"2012","unstructured":"Overstreet D.H.;  Psychiatric Disorders; Kobeissy, F; ED 2012,125-144","journal-title":"Psychiatric Disorders; Kobeissy, F; ED"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jneumeth.2008.09.018","volume":"177","author":"Flaisher-Grinberg S.","year":"2009","unstructured":"Flaisher-Grinberg S.; Overgaard S.; Einat H.; Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania. J Neurosci Methods 2009,177(1),44-50","journal-title":"J Neurosci Methods"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.1002\/9780470479216.corpsy0500","author":"Peterson C.","year":"2010","unstructured":"Peterson C.;  The Corsini Encyclopedia of Psychology 2010","journal-title":"The Corsini Encyclopedia of Psychology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.neubiorev.2005.03.019","volume":"29","author":"Henn F.A.","year":"2005","unstructured":"Henn F.A.; Vollmayr B.; Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev 2005,29(4-5),799-804","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.biopsych.2005.11.006","volume":"60","author":"Hasler G.","year":"2006","unstructured":"Hasler G.; Drevets W.C.; Gould T.D.; Gottesman I.I.; Manji H.K.; Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 2006,60(2),93-105","journal-title":"Biol Psychiatry"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2165\/00002018-199512020-00007","volume":"12","author":"Peet M.","year":"1995","unstructured":"Peet M.; Peters S.; Drug-induced mania. Drug Saf 1995,12(2),146-153","journal-title":"Drug Saf"},{"key":"ref=44","author":"Frey B.N.","unstructured":"Frey B.N.; Valvassori S.S.; R\u00e9us G.Z.; Martins M.R.; Petronilho F.C.; Bardini K.; Dal-Pizzol F.; Kapczinski F.; Quevedo J.;  Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania J Psychiatry\n\tNeurosci, 2006, 31(5), 326-332","journal-title":"Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania J Psychiatry\n\tNeurosci, 2006, 31(5), 326-332"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.neubiorev.2007.03.003","volume":"31","author":"Kato T.","year":"2007","unstructured":"Kato T.; Kubota M.; Kasahara T.; Animal models of bipolar disorder. Neurosci Biobehav Rev 2007,31(6),832-842","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0166-4328(00)00318-1","volume":"118","author":"Gould T.J.","year":"2001","unstructured":"Gould T.J.; Keith R.A.; Bhat R.V.; Differential sensitivity to lithium\u2019s reversal of amphetamine-induced open-field activity in two inbred strains of mice. Behav Brain Res 2001,118(1),95-105","journal-title":"Behav Brain Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/0278-5846(95)00123-D","volume":"19","author":"el-Mallakh R.S.","year":"1995","unstructured":"el-Mallakh R.S.; Harrison L.T.; Li R.; Changaris D.G.; Levy R.S.; An animal model for mania: preliminary results. Prog Neuropsychopharmacol Biol Psychiatry 1995,19(5),955-962","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1476-5381.2011.01318.x","volume":"164","author":"Young J.W.","year":"2011","unstructured":"Young J.W.; Henry B.L.; Geyer M.A.; Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol 2011,164(4),1263-1284","journal-title":"Br J Pharmacol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.3317\/jraas.2002.029","volume":"3","author":"Llorens-Cortes C.","year":"2002","unstructured":"Llorens-Cortes C.; Mendelsohn F.A.; Organisation and functional role of the brain angiotensin system. J Renin Angiotensin Aldosterone Syst 2002,3(Suppl. 1),S39-S48","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00441-006-0190-8","volume":"326","author":"von Bohlen und Halbach O.","year":"2006","unstructured":"von Bohlen und Halbach O.; Albrecht D.; The CNS renin-angiotensin system. Cell Tissue Res 2006,326(2),599-616","journal-title":"Cell Tissue Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pnpbp.2012.12.009","volume":"43","author":"Bild W.","year":"2013","unstructured":"Bild W.; Hritcu L.; Stefanescu C.; Ciobica A.; Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 2013,43,79-88","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.euroneuro.2015.08.005","volume":"25","author":"de Souza Gomes J.A.","year":"2015","unstructured":"de Souza Gomes J.A.; de Souza G.C.; Berk M.; Cavalcante L.M.; de Sousa F.C.F.; Budni J.; de Lucena D.F.; Quevedo J.; Carvalho A.F.; Mac\u00eado D.; Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms. Eur Neuropsychopharmacol 2015,25(11),2086-2097","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1042\/CS20160116","volume":"130","author":"Almeida-Santos A.F.","year":"2016","unstructured":"Almeida-Santos A.F.; Kangussu L.M.; Moreira F.A.; Santos R.A.; Aguiar D.C.; Campagnole-Santos M.J.; Anxiolytic- and antidepressant-like effects of angiotensin-(1-7) in hypertensive transgenic (mRen2)27 rats. Clin Sci (Lond) 2016,130(14),1247-1255","journal-title":"Clin Sci (Lond)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/1096-8628(20001204)96:6<733:AID-AJMG7>3.0.CO;2-8","volume":"96","author":"Furlong R.A.","year":"2000","unstructured":"Furlong R.A.; Keramatipour M.; Ho L.W.; Rubinsztein J.S.; Michael A.; Walsh C.; Paykel E.S.; Rubinsztein D.C.; No association of an insertion\/deletion polymorphism in the angiotensin I converting enzyme gene with bipolar or unipolar affective disorders. Am J Med Genet 2000,96(6),733-735","journal-title":"Am J Med Genet"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/S0006-3223(95)00597-8","volume":"40","author":"Arinami T.","year":"1996","unstructured":"Arinami T.; Li L.; Mitsushio H.; Itokawa M.; Hamaguchi H.; Toru M.; An insertion\/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders. Biol Psychiatry 1996,40(11),1122-1127","journal-title":"Biol Psychiatry"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00702-001-0686-z","volume":"109","author":"Hong C-J.","year":"2002","unstructured":"Hong C-J.; Wang Y-C.; Tsai S-J.; Association study of angiotensin I-converting enzyme polymorphism and symptomatology and antidepressant response in major depressive disorders. J Neural Transm (Vienna) 2002,109(9),1209-1214","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s007020070023","volume":"107","author":"Pauls J.","year":"2000","unstructured":"Pauls J.; Bandelow B.; R\u00fcther E.; Kornhuber J.; Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder. J Neural Transm (Vienna) 2000,107(11),1361-1366","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/15622970701459810","volume":"11","author":"Bandelow B.","year":"2010","unstructured":"Bandelow B.; Saleh K.; Pauls J.; Domschke K.; Wedekind D.; Falkai P.; Insertion\/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect? World J Biol Psychiatry 2010,11(1),66-70","journal-title":"World J Biol Psychiatry"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ajmg.b.30793","volume":"150B","author":"Sparks D.L.","year":"2009","unstructured":"Sparks D.L.; Hunsaker J.C.; Amouyel P.; Malafosse A.; Bellivier F.; Leboyer M.; Courtet P.; Helbecque N.; Angiotensin I-converting enzyme I\/D polymorphism and suicidal behaviors. Am J Med Genet B Neuropsychiatr Genet 2009,150B(2),290-294","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/sj.mp.4001884","volume":"11","author":"Baghai T.C.","year":"2006","unstructured":"Baghai T.C.; Binder E.B.; Schule C.; Salyakina D.; Eser D.; Lucae S.; Zwanzger P.; Haberger C.; Zill P.; Ising M.; Deiml T.; Uhr M.; Illig T.; Wichmann H.E.; Modell S.; Nothdurfter C.; Holsboer F.; M\u00fcller-Myhsok B.; M\u00f6ller H.J.; Rupprecht R.; Bondy B.; Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry 2006,11(11),1003-1015","journal-title":"Mol Psychiatry"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0304-3940(00)01512-3","volume":"293","author":"Meira-Lima I.V.","year":"2000","unstructured":"Meira-Lima I.V.; Pereira A.C.; Mota G.F.; Krieger J.E.; Vallada H.; Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans. Neurosci Lett 2000,293(2),103-106","journal-title":"Neurosci Lett"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/YPG.0b013e3283351194","volume":"20","author":"Kucukali C.I.","year":"2010","unstructured":"Kucukali C.I.; Aydin M.; Ozkok E.; Bilge E.; Zengin A.; Cakir U.; Kara I.; Angiotensin-converting enzyme polymorphism in schizophrenia, bipolar disorders, and their first-degree relatives. Psychiatr Genet 2010,20(1),14-19","journal-title":"Psychiatr Genet"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF00429057","volume":"45","author":"Altamura A.C.","year":"1975","unstructured":"Altamura A.C.; Morganti A.; Plasma renin activity in depressed patients treated with increasing doses of lithium carbonate. Psychopharmacology (Berl) 1975,45(2),171-175","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1192\/bjp.131.6.575","volume":"131","author":"Hullin R.P.","year":"1977","unstructured":"Hullin R.P.; Jerram T.C.; Lee M.R.; Levell M.J.; Tyrer S.P.; Renin and aldosterone relationships in manic depressive psychosis. Br J Psychiatry 1977,131(6),575-581","journal-title":"Br J Psychiatry"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-244X-3-15","volume":"3","author":"Murck H.","year":"2003","unstructured":"Murck H.; Held K.; Ziegenbein M.; K\u00fcnzel H.; Koch K.; Steiger A.; The renin-angiotensin-aldosterone system in patients with depression compared to controls--a sleep endocrine study. BMC Psychiatry 2003,3(1),15","journal-title":"BMC Psychiatry"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.psychres.2010.07.038","volume":"187","author":"Hallberg L.","year":"2011","unstructured":"Hallberg L.; Westrin A.; Isaksson A.; Janelidze S.; Tr\u00e4skman-Bendz L.; Brundin L.; Decreased aldosterone in the plasma of suicide attempters with major depressive disorder. Psychiatry Res 2011,187(1-2),135-139","journal-title":"Psychiatry Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.psyneuen.2013.03.015","volume":"38","author":"H\u00e4fner S.","year":"2013","unstructured":"H\u00e4fner S.; Baumert J.; Emeny R.T.; Lacruz M.E.; Bidlingmaier M.; Reincke M.; Ladwig K.H.; Hypertension and depressed symptomatology: a cluster related to the activation of the renin-angiotensin-aldosterone system (RAAS). Findings from population based KORA F4 study. Psychoneuroendocrinology 2013,38(10),2065-2074","journal-title":"Psychoneuroendocrinology"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1113\/EP086562","volume":"102","author":"Kalelioglu T.","year":"2017","unstructured":"Kalelioglu T.; Karamustafalioglu N.; Genc A.; Kocabiyik M.; Serum osmolarity in male patients with bipolar disorder manic episode. Exp Physiol 2017,102(10),1264-1268","journal-title":"Exp Physiol"},{"key":"ref=69","author":"Hubenak J.","unstructured":"Hubenak J.; Tuma I.; Bazant J.;  Association of arterial hypertension and cognitive impairment in euthymic bipolar disorder Neuroendocrinol. Lett., 2015, 36(3), 294-300.","journal-title":"Association of arterial hypertension and cognitive impairment in euthymic bipolar disorder"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.116.08188","volume":"68","author":"Boal A.H.","year":"2016","unstructured":"Boal A.H.; Smith D.J.; McCallum L.; Muir S.; Touyz R.M.; Dominiczak A.F.; Padmanabhan S.; Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders. Hypertension 2016,68(5),1132-1138","journal-title":"Hypertension"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(02)01283-9","volume":"438","author":"Gard P.R.","year":"2002","unstructured":"Gard P.R.; The role of angiotensin II in cognition and behaviour. Eur J Pharmacol 2002,438(1-2),1-14","journal-title":"Eur J Pharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nlm.2011.10.003","volume":"97","author":"Lazaroni T.L.","year":"2012","unstructured":"Lazaroni T.L.; Raslan A.C.S.; Fontes W.R.; de Oliveira M.L.; Bader M.; Alenina N.; Moraes M.F.; Dos Santos R.A.; Pereira G.S.; Angiotensin-(1-7)\/Mas axis integrity is required for the expression of object recognition memory. Neurobiol Learn Mem 2012,97(1),113-123","journal-title":"Neurobiol Learn Mem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","volume":"18","author":"Rodrigues Prestes T.R.","year":"2017","unstructured":"Rodrigues Prestes T.R.; Rocha N.P.; Miranda A.S.; Teixeira A.L.; Simoes-E-Silva A.C.; The anti-inflammatory potential of ACE2\/angiotensin-(1-7)\/mas receptor axis: Evidence from basic and clinical research. Curr Drug Targets 2017,18(11),1301-1313","journal-title":"Curr Drug Targets"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1113\/expphysiol.2008.042002","volume":"93","author":"Santos R.A.","year":"2008","unstructured":"Santos R.A.; Ferreira A.J.; Sim\u00f5es E Silva A.C.; Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008,93(5),519-527","journal-title":"Exp Physiol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.biopsych.2013.08.024","volume":"75","author":"Marvar P.J.","year":"2014","unstructured":"Marvar P.J.; Goodman J.; Fuchs S.; Choi D.C.; Banerjee S.; Ressler K.J.; Angiotensin type 1 receptor inhibition enhances the extinction of fear memory. Biol Psychiatry 2014,75(11),864-872","journal-title":"Biol Psychiatry"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1055\/s-0043-112345","volume":"50","author":"Wincewicz D.","year":"2017","unstructured":"Wincewicz D.; Braszko J.J.; Validation of brain angiotensin system blockade as a novel drug target in pharmacological treatment of neuropsychiatric disorders. Pharmacopsychiatry 2017,50(6),233-247","journal-title":"Pharmacopsychiatry"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","volume":"185","author":"da Silveira K.D.","year":"2010","unstructured":"da Silveira K.D.; Coelho F.M.; Vieira A.T.; Sachs D.; Barroso L.C.; Costa V.V.; Bretas T.L.B.; Bader M.; de Sousa L.P.; da Silva T.A.; dos Santos R.A.; Sim\u00f5es e Silva A.C.; Teixeira M.M.; Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J Immunol 2010,185(9),5569-5576","journal-title":"J Immunol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"Iwai M.","year":"2009","unstructured":"Iwai M.; Horiuchi M.; Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res 2009,32(7),533-536","journal-title":"Hypertens Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","volume":"465","author":"Bader M.","year":"2013","unstructured":"Bader M.; ACE2, angiotensin-(1\u20137), and Mas: the other side of the coin. Pflugers Arch 2013,465(1),79-85","journal-title":"Pflugers Arch"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3317\/jraas.2006.003","volume":"7","author":"Ferrario C.M.","year":"2006","unstructured":"Ferrario C.M.; Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst 2006,7(1),3-14","journal-title":"J Renin Angiotensin Aldosterone Syst"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/177717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T04:16:56Z","timestamp":1596341816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/177717\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866527666191223144000","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}